MVC’s WHO-Partnered Vaccine a First for Taiwan
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
Address: 6F, No 216-5, Sec. 2, Suiyuan Road, Taichung,Taiwan
Tel: +886 4 2247 3356
For over 15 years, with headquarter in central Taiwan and a branch office in Taipei, and as the pioneer of specialty pharmaceutical distribution locally, Giddi Pharma Co., Ltd. continues to provide excellent services to its global business partners, the local medical community, as well as patients’ advocacy and support groups.
Giddi’s expertise begins with comprehensive & extensive knowledge in various business channels and all distribution models. Its unique one-stop solution, turnkey service capacity has resulted in quick market entry with great efficiency plus cost-saving advantages. From individual named patient import to full scale commercial launch; from product registration, to insurance reimbursement and formulary listing; from international cold chain logistic to pharmacovigilance, Giddi offers comprehensive coverage in each and every aspect of product commercialization.
Giddi’s achievements include several ‘Distributor Excellent Performance Awards’ from Genzyme, 5 times ‘Special Contribution for Supply, Manufacture, Research & Development of Rare Disease Medications’ from Department of Health and Presidential ‘Golden Merchant Award’.
Synergism of innovative leadership with decades of experience from core management team has repeatedly enabled Giddi to formulate adaptive strategies, overcome all challenges and accomplish ultimate goals set by our principals. Each of its 64 employees is also 100% committed to the caring, professional, integrity motto with passion and responsibility.
Giddi’s achievements and successful track records have earned solid reputation and business from global companies like Genzyme, BioMarin, Ipsen and others. With 3 sales teams each dedicated to specific sector for in depth education and relationship cultivation, Giddi is able to maintain double digits growth year after year and becomes the industry leader.
Superior functional and technical expertise coupled with extensive industry knowledge makes Giddi Pharma the ideal choice for your local business partner in Taiwan!
As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its…
In an important milestone for Taiwan’s biotech industry, Diamond Biofund – one of the territory’s most well-established venture capital (VC) funds – became the first such firm to list on…
The latest pharma news from Taiwan, including Gongwin-KY’s lung cancer drug approval in China, Anxo Pharmaceutical/Genovior Biotech alliance, Taiwan’s Industrial Technology Research Institute (ITRI) and Metagone Biotech’s glaucoma and macular…
The latest healthcare and pharma news from Taiwan, including the CDMO Bora Pharmaceutical’s acquisition of Eden Biologics assets, the FDA fast track granted to the Taiwanese biomedical group United Biomedical’s…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what MVC’s competitive advantages are. At MVC we have…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their technology’s unique characteristics, how it differs from sequencing technologies in terms of cost and speed,…
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious internationalization plans, and comments on the vital role that companies like Leadgene have…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s rapid and coordinated response to the COVID-19 crisis and also explains how Quark Biosciences’ diagnostics and precision…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global…
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market, rising medical needs in Asia are helping foster more regionally-focused strategies. …
All country managers of multinational pharma companies need to strike the balance between having a global outlook and adapting to local culture. For BoonHuey Ee, general manager of Merck Biopharma…
See our Cookie Privacy Policy Here
